StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright raised their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Stock Report on SenesTech
SenesTech Stock Down 2.1 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- Canada Bond Market Holiday: How to Invest and Trade
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The 3 Best Retail Stocks to Shop for in August
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Profitably Trade Stocks at 52-Week Highs
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.